Results 181 to 190 of about 3,355,558 (275)

Promoting smoking cessation and preventing relapse to tobacco use following a smokefree mental health in‐patient stay: A multi‐centre randomised controlled feasibility study

Addiction, Volume 121, Issue 11, Page 3084-3105, November 2026.
Abstract Aims This study assessed the feasibility and acceptability of a new theory‐ and evidence‐based intervention designed to prevent return to pre‐admission smoking behaviours after discharge from a smokefree mental health in‐patient setting in the United Kingdom (UK).
Petal Petersen Williams, Lisa Huddlestone, Emily Shoesmith, Jennifer Sweetman, Heidi Stevens, Alex Mitchell, Fraser Wiggins, Lesley Sinclair, Victoria Exley, Catherine Hewitt, Judith Watson, Qi Wu, Jodi Pervin, Moira Leahy, Claire Paul, Lion Shahab, Michelle Horspool, Tim Coleman, Simon Hough, Elena Ratschen, the SCEPTRE Collaboration team, Lesley Colley, Samantha Brady, John Britton, Simon Gilbody, Steve Parrott, Peter Coventry, Gregor Russell, Paul Galdas   +28 more
wiley   +1 more source

Real-world effectiveness of cytisine, bupropion, and nicotine replacement therapy in a smoking cessation clinic: A single-center retrospective cohort study. [PDF]

Tob Induc Dis
Aksoy HB.
europepmc   +1 more source

Impact of mental health disorders on problematic substance use and effectiveness of brief intervention among young people in foster care

Addiction, Volume 121, Issue 11, Page 3106-3120, November 2026.
Abstract Background and aims Brief interventions delivered in healthcare settings represent a promising substance use prevention and early intervention strategy for youth in foster care, among whom early life adversity and resulting psychological sequalae increase risk for problematic substance use.
Courtney B. Dunn, Austin Blake, Katie Fox, Mary V. Greiner, Sarah J. Beal   +4 more
wiley   +1 more source

Decision-Making on Nicotine Replacement Therapy Use and Product Selection: An Explorative Qualitative Study Among Chinese Americans Who Smoke. [PDF]

Int J Environ Res Public Health
Jiang N, Yang J, Kaplan SA, Rogers ES, Tsoh JY, Lyu JC, Sherman SE.   +6 more
europepmc   +1 more source

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

The American Journal on Addictions, Volume 35, Issue 6, Page 661-672, November 2026.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan, Nazli Tunali, R. Andrew Chambers   +2 more
wiley   +1 more source

Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective

The Clinical Respiratory Journal, Volume 20, Issue 11, November 2026.
This review summarizes recent advances in combined pulmonary fibrosis and emphysema (CPFE), proposing a novel etiologic classification framework encompassing four subtypes. We integrate a diagnostic algorithm to guide precise management and highlight emerging artificial intelligence strategies for risk stratification and dynamic prognostic assessment ...
Qinyu Deng, Chen Chen, Qinghe Zhang, Zilin Wei, Jianqi Sun, Feng Li   +5 more
wiley   +1 more source

Evaluating Harm Reduction Advice From Large Language Models

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Large language models (LLM) and generative Artificial Intelligence are increasingly providing health information. We have applied a novel method to evaluate the harm reduction information generated by popular LLMs. We focused on the filtration of oral medications for injection and the availability of local harm reduction services.
Khy Choo, Nathan Smith, Bernadette Ward, Robert M. Lundin   +3 more
wiley   +1 more source

Preloading With Nicotine Replacement Therapy in People With HIV Who Smoke: A Pilot Randomized Controlled Trial. [PDF]

Nicotine Tob Res
Cioe PA, Stang GS, Azam D, Piper ME, Kahler CW.   +4 more
europepmc   +1 more source

Are Increases in Purchasing Alcohol‐Free and Low‐Alcohol Drinks Associated With Attempts to Cut Down on Alcohol Consumption in England? A Time Series Analysis

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Alcohol‐free and low‐alcohol products (≤ 1.2% ABV; no/lo products) are a growing market in high‐income countries, including Great Britain. These products may support people in reducing alcohol consumption, but their impact on public health is unclear.
Abigail K. Stevely, Inge Kersbergen, Jamie Brown, Ellen McGrane, Sarah Jackson, Luke B. Wilson, John Holmes   +6 more
wiley   +1 more source

An Observational Study of Nicotine Replacement Therapy Availability Through Pharmacist Prescribing in the California Central Valley. [PDF]

Tob Use Insights
Halliday DM, Schneider S, Wakefield T, Durazo A, Tracy D, Song AV, Apollonio DE.   +6 more
europepmc   +1 more source